Page last updated: 2024-08-23

penfluridol and Leukemia, Myeloid, Acute

penfluridol has been researched along with Leukemia, Myeloid, Acute in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chien, MH; Chow, JM; Ku, CC; Lee, WJ; Wen, YC; Wu, SY; Yang, SF; Yang, YC	1

Other Studies

1 other study(ies) available for penfluridol and Leukemia, Myeloid, Acute

Article	Year
Penfluridol triggers cytoprotective autophagy and cellular apoptosis through ROS induction and activation of the PP2A-modulated MAPK pathway in acute myeloid leukemia with different FLT3 statuses. Journal of biomedical science, 2019, Aug-31, Volume: 26, Issue:1 Topics: Antipsychotic Agents; Apoptosis; Autophagy; Cell Line, Tumor; Cytoprotection; fms-Like Tyrosine Kinase 3; HL-60 Cells; Humans; Leukemia, Myeloid, Acute; Mitogen-Activated Protein Kinases; Penfluridol; Protein Phosphatase 2; Reactive Oxygen Species; Signal Transduction; U937 Cells	2019

Article

Year

Penfluridol triggers cytoprotective autophagy and cellular apoptosis through ROS induction and activation of the PP2A-modulated MAPK pathway in acute myeloid leukemia with different FLT3 statuses.

Journal of biomedical science, 2019, Aug-31, Volume: 26, Issue:1

Topics: Antipsychotic Agents; Apoptosis; Autophagy; Cell Line, Tumor; Cytoprotection; fms-Like Tyrosine Kinase 3; HL-60 Cells; Humans; Leukemia, Myeloid, Acute; Mitogen-Activated Protein Kinases; Penfluridol; Protein Phosphatase 2; Reactive Oxygen Species; Signal Transduction; U937 Cells

2019